ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
118.532,68
-1,33%
S&P 500
5.942,47
1,26%
US Dollar vs BRL
6,1822
0,00%
Bitcoin
98.331,35
0,23%
Brent Oil
76,495
0,00%
As Melhores Corretoras Online
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. AlloVir Inc (ALVR)

  7. AlloVir Inc (ALVR) Notícias

ALVR

AlloVir (ALVR)

AlloVir Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALVR
DataHoraFonteTítuloCódigoCompanhia
20/12/202418:23Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ALVRAlloVir Inc
20/12/202418:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
09/12/202408:37Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:ALVRAlloVir Inc
06/12/202409:23Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ALVRAlloVir Inc
26/11/202418:33Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ALVRAlloVir Inc
20/11/202418:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
19/11/202422:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
11/10/202417:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ALVRAlloVir Inc
09/08/202410:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALVRAlloVir Inc
02/08/202419:25Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ALVRAlloVir Inc
14/03/202407:10PR Newswire (US)Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:ALVRAlloVir Inc
07/03/202407:45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVRNASDAQ:ALVRAlloVir Inc
15/02/202418:30Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ALVRAlloVir Inc
09/02/202407:45PR Newswire (US)Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:ALVRAlloVir Inc
02/02/202407:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of AlloVir, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024 - (NASDAQ: ALVR)NASDAQ:ALVRAlloVir Inc
09/01/202414:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALVRAlloVir Inc
09/01/202414:29Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ALVRAlloVir Inc
05/01/202408:14IH Market NewsWall Street Highlights: Google Rejects Union Negotiations, Exxon Mobil Announces $2.5 Billion Accounting Write-Down in CaliforniaNASDAQ:ALVRAlloVir Inc
22/12/202309:00GlobeNewswire Inc.AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell TherapyNASDAQ:ALVRAlloVir Inc
16/11/202309:00Business WireAlloVir to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:ALVRAlloVir Inc
02/11/202308:00Business WireAlloVir Reports Third Quarter 2023 Financial ResultsNASDAQ:ALVRAlloVir Inc
28/08/202308:00Business WireAlloVir to Present at Upcoming Investor ConferencesNASDAQ:ALVRAlloVir Inc
03/08/202308:00Business WireAlloVir Reports Second Quarter 2023 Financial ResultsNASDAQ:ALVRAlloVir Inc
12/07/202308:41IH Market NewsWednesday’s Wall Street Highlights: Nvidia, VMware, Alphabet, Coty, IBM, and moreNASDAQ:ALVRAlloVir Inc
26/06/202317:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALVRAlloVir Inc
22/06/202318:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ALVRAlloVir Inc
21/06/202322:20Business WireAlloVir Announces Pricing of Public Offering of Common StockNASDAQ:ALVRAlloVir Inc
21/06/202318:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALVRAlloVir Inc
21/06/202317:18Business WireAlloVir Announces Proposed Public Offering of Common StockNASDAQ:ALVRAlloVir Inc
13/06/202318:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALVRAlloVir Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALVR

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
USIM5
USIMINAS PNA
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
AMBP3
Ambipar Participacoes e ... ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
BRSR6
BANRISUL PNB
BOV
INBR32
Inter &
BOV
GFSA3
GAFISA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados